Cargando…
Novel multi-kinase inhibitor, T03 inhibits Taxol-resistant breast cancer
Activation of kinase-associated signaling pathways is one of the leading causes of various malignant phenotypes in breast tumors. Strategies of drug discovery and development have investigated approaches to target the inhibition of protein kinase signaling. In the current study, the anti-tumor activ...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783483/ https://www.ncbi.nlm.nih.gov/pubmed/29207185 http://dx.doi.org/10.3892/mmr.2017.8179 |